4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-017567
CBO & EVP sold 4,572 shares at $138.17 ($631,713)
- CBO & EVP acquired 10,136 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kassberg Thomas Richard CBO & EVP | 2021-03-01 | Grant or award | +5,500 | 106,978 | D: show line 1 in the form | ||
| Kassberg Thomas Richard CBO & EVP | 2021-03-01 | Grant or award | +4,636 | 111,614 | D: show line 2 in the form | ||
| Kassberg Thomas Richard CBO & EVP | 2021-03-01 | Sale | −4,572 | $138.17 | $631,713 | 107,181 | D: show line 3 in the form |
| Open-market sales · 4,572 sh · avg $138.17 · $631,713 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Kassberg Thomas Richard CBO & EVP | 2021-03-01 | Grant or award · Stock Option (Right to Buy) | +11,000 | 11,000 | D: show line 4 in the form |
Loading xslF345X03/doc4.xml…